San Diego-based mostly Viking Therapeutics marked alone as a serious competitor during the weight loss drug market in February just after revealing promising info from a mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in March the company